Vaccine Design and Testing – Products

The Life Science Group Sartorius has launched the new Octet® SF3, the first Surface Plasmon Resonance (SPR) system under the Sartorius Octet® brand.

Quality Assurance in In Vitro Transcribed RNA Vaccine Development Using Agilent Automated Electrophoresis Instruments

PacBio today announced the release of a transformative capability to detect DNA methylation using the Sequel IIe and Sequel II Systems.

Program participants receive early access to the upcoming release of kits designed to print longer oligos and enable labeling with fluorophores, quenchers and biotin.

Although most mutations have minimal impact on the characteristics of the virus, some may affect its transmissibility, the severity of associated diseases and the efficacy of diagnostics, preventives and treatments.

Octet® BLI platforms are helping accelerate research on Coronavirus by providing:

High-throughput kinetic interaction analysis solutions to rapidly select and characterize vaccine and therapeutic candidates

Efficient workflows for vaccine and biotherapeutic development research

Fast and flexible platform 

Versatile solutions in upstream and downstream vaccine development

AMSBIO has announced new additions to its portfolio of tools for COVID-19 research - two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2.

Sino Biological, Inc. has announced that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus, which quickly raised concerns around the world because of the high number of mutations it carries, especially the 30-plus mutations on the Spike protein.

Charged Aerosol detection (CAD) can be used to complement your HPLC-UV analysis in a situation where excipients in a formula are a mix of UV active and inactive components. Using these tools together gives you a robust and reliable analytical detection method to determine the stability of all vaccine excipients.

BioNet and BIA Separations, now part of Sartorius, have announced the successful development of an optimized mRNA manufacturing process.